Middle East Livestock Health Market Size, Share and Forecast Trends - Growth Analysis and Outlook Report 2026-2030

The Middle East and Africa livestock health market covers products and services for preventing and treating diseases in food-producing animals, including cattle, poultry, sheep, goats, and camels. Regional market size estimates range from $4.08 billion to $5.48 billion depending on scope definitions, with the broader animal healthcare sector projected near $5.54 billion by 2026. The market spans veterinary pharmaceuticals, vaccines, feed additives, and diagnostic services across diverse climatic and agricultural conditions.

• •Veterinary healthcare segment valued at $4.08 billion in 2025, expected to reach $4.36 billion
• •Broader animal health sector estimated at $5.48 billion in 2025
• •Market encompasses pharmaceuticals, vaccines, feed additives, and diagnostics

Rising per-capita meat and dairy consumption across the Middle East and Africa is pushing livestock intensification, which in turn increases demand for health products and biosecurity measures. Urbanization, population growth, and expanding middle-class purchasing power are amplifying protein demand. Additionally, recurrent disease outbreaks and trade requirements are pushing producers toward greater vaccination coverage and herd health management.

• •Animal feed market in MEA projected at approximately 3.4% CAGR through 2030
• •Protein demand growth driving herd size expansion in key producing nations
• •Disease prevention mandates and export requirements boosting vaccine and pharmaceutical uptake

The market divides into veterinary pharmaceuticals, vaccines, medicated feed additives, and diagnostic services, with pharmaceuticals and vaccines representing the largest revenue share. Geographically, the Gulf Cooperation Council states and larger African livestock-producing nations anchor the market, while sub-Saharan Africa presents higher growth potential from lower current penetration. Feed additives segment ties closely to the broader animal nutrition market, which is expanding at its own moderate pace.

• •Pharmaceuticals and vaccines dominate current revenue composition
• •GCC states show higher per-unit spending; African markets offer volume-driven growth
• •Medicated feed additives segment growing alongside conventional feed markets

Who are the notable companies in the industry?

The regional market structure ranges from fragmented in smaller African nations to moderately consolidated in the Gulf states, with no single provider holding dominant share across the entire Middle East & Africa region. Vertically integrated multinational groups, including Zoetis, Merck Animal Health, Elanco Animal Health, Boehringer Ingelheim Animal Health, Ceva Sante Animale, and Virbac, compete alongside smaller regional specialists focusing on specific product categories or species, leveraging their established manufacturing and distribution networks to serve cross-border demand. Production capacity is concentrated in a limited number of manufacturing hubs that feed into regional distribution networks, reinforcing the advantage of scale for larger players while creating entry barriers for new competitors. Competitive positioning increasingly hinges on species-specific portfolio depth and the ability to deliver tailored solutions across the region's diverse livestock systems.

• •Mix of integrated multinational suppliers and regional specialty producers
• •Manufacturing capacity concentrated in a few regional hubs serving broader distribution networks
• •Structure varies by country: more consolidated in GCC, more fragmented in sub-Saharan Africa

What are the recent trends and outlook?

The market is expected to maintain its mid-single-digit growth trajectory through the forecast period, supported by continued livestock sector expansion and modernization. Innovation in vaccine delivery, digital livestock management tools, and preventive healthcare protocols are gaining attention. Regulatory harmonization efforts across trade blocs and increasing veterinary infrastructure investment are likely to shape competitive dynamics.

• •5.4% CAGR expected to continue through 2026 and beyond
• •Digital health monitoring and precision livestock farming emerging as growth areas
• •Regulatory convergence and local production incentives may reshape supply chains